The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Scleroderma lung disease
Open accessAbstract
Systemic sclerosis (SSc) is a systemic autoimmune disease that is characterised by endothelial dysfunction resulting in a small-vessel vasculopathy, fibroblast dysfunction with resultant excessive collagen production and fibrosis, and immunological abnormalities. The classification of SSc is subdivided based on the extent of skin involvement into diffuse cutaneous sclerosis (dcSSc), limited cutaneous sclerosis (lcSSc) or SSc sine scleroderma [1]. While virtually any organ system may be involved in the disease process, fibrotic and vascular pulmonary manifestations of SSc, including interstitial lung disease (ILD) and pulmonary hypertension (PH), are the leading cause of death. As new therapies targeting these pulmonary conditions emerge, early recognition of lung involvement is essential for the care of these patients. In this article we review the direct and indirect pulmonary manifestations of SSc and recent therapeutic trials that have attempted to target these manifestations. When a patient with SSc disease presents with signs or symptoms referring to the chest, a number of potential disorders must be considered (table 1) for: direct pulmonary involvement (ILD with or without PH or pulmonary arterial hypertension (PAH), airways disease and pleural involvement); indirect pulmonary complications (aspiration, infection, drug toxicity, malignancy, respiratory muscle weakness, restrictive lung disease from chest wall involvement and lung disease secondary to cardiac involvement); combinations of direct and indirect pulmonary manifestations; and other lung diseases not related to SSc (chronic obstructive pulmonary disease/emphysema, asthma and lung nodules). View this table: Table 1. Pulmonary involvement in systemic sclerosis In scleroderma, the two most common types of direct pulmonary involvement are ILD and PH, which together account for 60% of SSc-related deaths [2]. While certain pulmonary manifestations may occur more commonly in a subset of SSc ( i.e. ILD is more common in dcSSc while PH is more common in lcSSc) [3], all of the known pulmonary manifestations reported have been described in each of …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Cyclophosphamide versus placebo in scleroderma lung disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D. E., Arriola, E., Silver, R., Strange, C., Bolster, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055120 · Cited by 1,677
Changes in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Tyndall, A. J., Bannert, B., Vonk, M., Airò, P., Cozzi, F., Carreira, P. E., Bancel, D. F., Allanore, Y., Müller-Ladner, U., Distler, O., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.114264 · Cited by 1,443
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System
Goh, N. S. L., Desai, S. R., Veeraraghavan, S., Hansell, D. M., Copley, S. J., Maher, T. M., Corte, T. J., Sander, C. R., Ratoff, J., Devaraj, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-877oc · Cited by 1,230
Galiè, N., Torbicki, A., Barst, R. J., Dartevelle, P., Haworth, S. G., Higenbottam, T., Olschewski, H., Peacock, A. J., Pietra, G., Rubin, L. J., et al. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.09.014 · Cited by 1,194
Diagnosis and Assessment of Pulmonary Arterial Hypertension
Badesch, D. B., Champion, H. C., Gomez Sanchez, M. A., Hoeper, M. M., Loyd, J. E., Manes, A., McGoon, M., Naeije, R., Olschewski, H., Oudiz, R. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.011 · Cited by 1,138
Pathologic observations in systemic sclerosis (scleroderma)
D'Angelo, W. A., Fries, J. F., Masi., A. T., & Shulman, L. E. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90044-8 · Cited by 1,111
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,103
Galiè, N., Olschewski, H., Oudiz, R. J., Torres, F., Frost, A., Ghofrani, H. A., Badesch, D. B., McGoon, M. D., McLaughlin, V. V., Roecker, E. B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.742510 · Cited by 1,083
Badesch, D. B., Tapson, V. F., McGoon, M. D., Brundage, B. H., Rubin, L. J., Wigley, F. M., Rich, S., Barst, R. J., Barrett, P. S., Kral, K. M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00002 · Cited by 1,075
Walker, U. A., Tyndall, A., Czirják, L., Denton, C., Farge-Bancel, D., Kowal-Bielecka, O., Müller-Ladner, U., Bocelli-Tyndall, C., & Matucci-Cerinic, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062901 · Cited by 929
Bouros, D., Wells, A. U., Nicholson, A. G., Colby, T. V., Polychronopoulos, V., Pantelidis, P., Haslam, P. L., Vassilakis, D. A., Black, C. M., & du Bois, R. M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2106012 · Cited by 820
Mukerjee, D., St George, D., Coleiro, B., Knight, C., Denton, C. P., Davar, J., Black, C. M., & Coghlan, J. G. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1088 · Cited by 764
Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance
Katzenstein, A.-L. A., & Fiorelli, R. F. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199402000-00003 · Cited by 755
Hachulla, E., Gressin, V., Guillevin, L., Carpentier, P., Diot, E., Sibilia, J., Kahan, A., Cabane, J., Francès, C., Launay, D., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21433 · Cited by 745
Hoyles, R. K., Ellis, R. W., Wellsbury, J., Lees, B., Newlands, P., Goh, N. S. L., Roberts, C., Desai, S., Herrick, A. L., McHugh, N. J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22204 · Cited by 732
Autoantibodies in Systemic Sclerosis
Steen, V. D. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.03.005 · Cited by 684
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
McLaughlin, V. V., Oudiz, R. J., Frost, A., Tapson, V. F., Murali, S., Channick, R. N., Badesch, D. B., Barst, R. J., Hsu, H. H., & Rubin, L. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-358oc · Cited by 626
Kowal-Bielecka, O., Landewé, R., Avouac, J., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096677 · Cited by 619
Burt, R. K., Shah, S. J., Dill, K., Grant, T., Gheorghiade, M., Schroeder, J., Craig, R., Hirano, I., Marshall, K., Ruderman, E., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60982-3 · Cited by 578
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
McLaughlin, V. V., Benza, R. L., Rubin, L. J., Channick, R. N., Voswinckel, R., Tapson, V. F., Robbins, I. M., Olschewski, H., Rubenfire, M., & Seeger, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.027 · Cited by 566
Severe restrictive lung disease in systemic sclerosis
Steen, V. D., Conte, C., Owens, G. R., & Medsger, T. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370903 · Cited by 526
Steen, V., & Medsger, T. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10775 · Cited by 494
Felson, D. T., Anderson, J. J., Lange, M. L. M., Wells, G., & LaValley, M. P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 474
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Roth, M. D., Furst, D. E., Silver, R. M., Goldin, J., Arriola, E., Strange, C., Bolster, M. B., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-326oc · Cited by 464
Kawut, S. M., Taichman, D. B., Archer-Chicko, C. L., Palevsky, H. I., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.123.2.344 · Cited by 427
Desai, S. R., Veeraraghavan, S., Hansell, D. M., Nikolakopolou, A., Goh, N. S. L., Nicholson, A. G., Colby, T. V., Denton, C. P., Black, C. M., du Bois, R. M., et al. (2004) · Radiology · doi:10.1148/radiol.2322031223 · Cited by 394
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
Daoussis, D., Liossis, S.-N. C., Tsamandas, A. C., Kalogeropoulou, C., Kazantzi, A., Sirinian, C., Karampetsou, M., Yiannopoulos, G., & Andonopoulos, A. P. (2010) · Rheumatology · doi:10.1093/rheumatology/kep093 · Cited by 394
White, B., Moore, W. C., Wigley, F. M., Xiao, H. Q., & Wise, R. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00004 · Cited by 384
Pulmonary hypertension in the crest syndrome variant of systemic sclerosis
Stupi, A. M., Steen, V. D., Owens, G. R., Barnes, E. L., Rodnan, G. P., & Medsger, T. A. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290409 · Cited by 367
Clinical differences between idiopathic and scleroderma‐related pulmonary hypertension
Fisher, M. R., Mathai, S. C., Champion, H. C., Girgis, R. E., Housten‐Harris, T., Hummers, L., Krishnan, J. A., Wigley, F., & Hassoun, P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22069 · Cited by 349
AVOUAC, J., AIRÒ, P., MEUNE, C., BERETTA, L., DIEUDE, P., CARAMASCHI, P., TIEV, K., CAPPELLI, S., DIOT, E., VACCA, A., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100245 · Cited by 333
Denton, C. P., Cailes, J. B., Phillips, G. D., Wells, A. U., Black, C. M., & Bois, R. M. (1997) · Rheumatology · doi:10.1093/rheumatology/36.2.239 · Cited by 323
Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)
NORTON, W. L., & NARDO, J. M. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-2-317 · Cited by 304
Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography.
Schurawitzki, H., Stiglbauer, R., Graninger, W., Herold, C., Pölzleitner, D., Burghuber, O. C., & Tscholakoff, D. (1990) · Radiology · doi:10.1148/radiology.176.3.2389033 · Cited by 292
Hachulla, A.-L., Launay, D., Gaxotte, V, de Groote, P., Lamblin, N., Devos, P., Hatron, P.-Y., Beregi, J.-P., & Hachulla, E. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.095836 · Cited by 280
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
Malik, S. W., Myers, J. L., DeRemee, R. A., & Specks, U. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.6.8970380 · Cited by 274
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma: A Study Using pH-Impedance Monitoring
Savarino, E., Bazzica, M., Zentilin, P., Pohl, D., Parodi, A., Cittadini, G., Negrini, S., Indiveri, F., Tutuian, R., Savarino, V., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1359oc · Cited by 269
Mathai, S. C., Hummers, L. K., Champion, H. C., Wigley, F. M., Zaiman, A., Hassoun, P. M., & Girgis, R. E. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24267 · Cited by 265
Wells, A. U., Cullinan, P., Hansell, D. M., Rubens, M. B., Black, C. M., Newman-Taylor, A. J., & Du Bois, R. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.6.8004317 · Cited by 265
Oudiz, R. J., Schilz, R. J., Barst, R. J., Galié, N., Rich, S., Rubin, L. J., & Simonneau, G. (2004) · Chest · doi:10.1378/chest.126.2.420 · Cited by 264
Cool, C. D., Kennedy, D., Voelkel, N. F., & Tuder, R. M. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90032-0 · Cited by 263
Ungerer, R. G., Tashkin, D. P., Furst, D., Clements, P. J., Gong, H., Bein, M., Smith, J. W., Roberts, N., & Cabeen, W. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91169-5 · Cited by 262
Song, J. W., Do, K.-H., Kim, M.-Y., Jang, S. J., Colby, T. V., & Kim, D. S. (2009) · Chest · doi:10.1378/chest.08-2572 · Cited by 248
Isolated diffusing capacity reduction in systemic sclerosis
Steen, V. D., Graham, G., Conte, C., Owens, G., & Medsger, T. A. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350709 · Cited by 241
Evaluation and management of scleroderma lung disease using bronchoalveolar lavage
Silver, R. M., Miller, K. S., Kinsella, M. B., Smith, E. A., & Schabel, S. I. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90425-d · Cited by 236
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
Teixeira, L., Mouthon, L., Mahr, A., Berezné, A., Agard, C., Mehrenberger, M., Noël, L.-H., Trolliet, P., Frances, C., Cabane, J., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066985 · Cited by 235
Hsu, E., Shi, H., Jordan, R. M., Lyons-Weiler, J., Pilewski, J. M., & Feghali-Bostwick, C. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30159 · Cited by 226
Esophageal involvement and pulmonary manifestations in systemic sclerosis
Marie, I., Dominique, S., Levesque, H., Ducrott�, P., Denis, P., Hellot, M.-F., & Courtois, H. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)45:4<346::aid-art347>3.0.co;2-l · Cited by 214
Mcnearney, T. A., Reveille, J. D., Fischbach, M., Friedman, A. W., Lisse, J. R., Goel, N., Tan, F. K., Zhou, X., Ahn, C., Feghali‐Bostwick, C. A., et al. (2007) · Arthritis Care & Research · doi:10.1002/art.22532 · Cited by 204
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis
Nihtyanova, S. I., Brough, G. M., Black, C. M., & Denton, C. P. (2007) · Rheumatology · doi:10.1093/rheumatology/kel244 · Cited by 204
Silver, R. M., Warrick, J. H., Kinsella, M., Staudt, L. S., Baumann, M. H., & Strange, C. (1993) · PubMed · Cited by 200
Meune, C., Avouac, J., Wahbi, K., Cabanes, L., Wipff, J., Mouthon, L., Guillevin, L., Kahan, A., & Allanore, Y. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23463 · Cited by 197
High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis.
Launay, D., Rémy-Jardin, M., Michon-Pasturel, U., Mastora, I., HACHULLA, E., Lambert, M., Delannoy, V., Queyrel, V., Duhamel, A., Matran, R., et al. (2006) · PubMed · Cited by 189
Therapy for severe interstitial lung disease in systemic sclerosis. a retrospective study
Steen, V. D., Lanz, J. K., Conte, C., Owens, G. R., & Medsger, T. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370904 · Cited by 184
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
Overbeek, M. J., Vonk, M. C., Boonstra, A., Voskuyl, A. E., Vonk-Noordegraaf, A., Smit, E. F., Dijkmans, B. A. C., Postmus, P. E., Mooi, W. J., Heijdra, Y., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00106008 · Cited by 184
Daoussis, D., Liossis, S. C., Tsamandas, A. C., Kalogeropoulou, C. P., Paliogianni, F., Sirinian, C., Yiannopoulos, G., & Andonopoulos, A. P. (2012) · PubMed · Cited by 183
Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic Sclerosis
Okano, Y., Steen, V. D., & Medsger, T. A. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350114 · Cited by 183
Liossis, S. N. C., Bounas, A., & Andonopoulos, A. P. (2006) · Rheumatology · doi:10.1093/rheumatology/kei211 · Cited by 179
Goh, N. S. L., Veeraraghavan, S., Desai, S. R., Cramer, D., Hansell, D. M., Denton, C. P., Black, C. M., du Bois, R. M., & Wells, A. U. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22696 · Cited by 177
Tamby, M. C. (2005) · Thorax · doi:10.1136/thx.2004.029082 · Cited by 174
Schachna, L., Medsger, T. A., Dauber, J. H., Wigley, F. M., Braunstein, N. A., White, B., Steen, V. D., Conte, J. V., Yang, S. C., McCurry, K. R., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22264 · Cited by 171
Pulmonary involvement in systemic sclerosis (scleroderma)
Steen, V. D., Owens, G. R., Fino, G. J., Rodnan, G. P., & Medsger, T. A. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280706 · Cited by 168
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis
Steele, R. J., Hudson, M., Lo, E., & Baron, M. G. (2011) · Arthritis Care & Research · doi:10.1002/acr.21583 · Cited by 162
Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension
Nickel, N. P., Kempf, T., Tapken, H., Tongers, J., Laenger, F., Lehmann, U., Golpon, H. A., Olsson, K. M., Wilkins, M. R., Gibbs, J. S. R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-235oc · Cited by 162
Wells, A. U., Hansell, D. M., Rubens, M. B., King, A. D., Cramer, D., Black, C. M., & Du Bois, R. M. (1997) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199707)40:7<1229::aid-art6>3.0.co;2-w · Cited by 162
Trad, S., Amoura, Z., Beigelman‐Aubry, C., Haroche, J., Costedoat-Chalumeau, N., Boutin, L. T. H. D., Cacoub, P., Francès, C., Wechsler, B., Greniér, P., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21538 · Cited by 158
Prevalence of pulmonary hypertension in limited and diffuse scleroderma
Battle, R. W., Davitt, M. A., Cooper, S. M., Buckley, L. M., Leib, E. S., Beglin, P. A., & Tischler, M. D. (1996) · Chest · doi:10.1378/chest.110.6.1515 · Cited by 158
Christmann, R., Wells, A. U., Capelozzi, V. L., et al. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2010.03.002 · Cited by 153
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension
Tamby, M. C., Humbert, M. J. C., Guilpain, P., Servettaz, A., Dupin, N., Christner, J. J., Simonneau, G., Fermanian, J., Weill, B. J., Guillevin, L., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00152705 · Cited by 151
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide
Åkesson, A., Scheja, A., Lundin, A., & Wollheim, F. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370518 · Cited by 150
New insights into the pathogenesis of systemic sclerosis
Tamby, M. C., Chanseaud, Y., Guillevin, L., & Mouthon, L. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00004-1 · Cited by 147
Stratton, R. J. (2001) · British journal of rheumatology · doi:10.1093/rheumatology/40.1.84 · Cited by 142
Nannini, C., West, C. P., Erwin, P. J., & Matteson, E. L. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2534 · Cited by 141
Scleroderma patients with combined pulmonary hypertension and interstitial lung disease.
Chang, B. W., Wigley, F. M., White, B., & Wise, R. A. (2003) · PubMed · Cited by 139
Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis
Briggs, D., Vaughan, R. W., Welsh, K. I., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91235-m · Cited by 136
Predictors of end stage lung disease in a cohort of patients with scleroderma
Morgan, C., Knight, C., Lunt, M., Black, C. M., & Silman, A. J. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.2.146 · Cited by 128
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis
Bolster, M. B., Ludwicka, A., Sutherland, S. E., Strange, C., & Silver, R. M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400422 · Cited by 125
Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?
HACHULLA, E., Launay, D., Mouthon, L., Sitbon, O., BEREZNE, A., Guillevin, L., Hatron, P., Simonneau, G., Clerson, P., & Humbert, M. J. C. (2009) · CHEST Journal · doi:10.1378/chest.08-3042 · Cited by 123
Launay, D., Mouthon, L., HACHULLA, E., Pagnoux, C., de Groote, P., Rémy‐Jardin, M., Matran, R., Lambert, M., Queyrel, V., Morell‐Dubois, S., et al. (2007) · PubMed · Cited by 121
Chang, B. W., Schachna, L., White, B., Wigley, F. M., & Wise, R. A. (2006) · PubMed · Cited by 121
Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis
Maddern, G. J., Horowitz, M., Jamieson, G. G., Chatterton, B. E., Collins, P., & Roberts-Thomson, P. J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90089-1 · Cited by 115
Esophageal Involvement in Scleroderma: Gastroesophageal Reflux, the Common Problem
Ntoumazios, S. K., Voulgari, P. V., Potsis, K., Koutis, E., Tsifetaki, N., & Assimakopoulos, D. A. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.08.002 · Cited by 114
Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma
Dib, H., Tamby, M. C., Bussone, G., Régent, A., BEREZNE, A., Lafine, C., Broussard, C., Simonneau, G., Guillevin, L., Witko‐Sarsat, V., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00181410 · Cited by 113
Phung, S., Strange, G. A., Chung, L. P., Leong, J., Dalton, B. S., Roddy, J., Deague, J. A., Playford, D. A., Musk, M., & Gabbay, E. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01823.x · Cited by 103
Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.
Fischer, A., Pfalzgraf, F. J., Feghali‐Bostwick, C. A., Wright, T. M., Curran‐Everett, D., West, S. G., & Brown, K. K. (2006) · PubMed · Cited by 90
Self-citationThe Toxicity of D-Penicillamine in Systemic Sclerosis
Steen, V. D., BLAIR, S., & MEDSGER, T. A. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-5-699 · Cited by 88
Polisson, R. P., Gilkeson, G. S., Pyun, E., Pisetsky, D. S., Smith, E. A., & Simon, L. S. (1996) · PubMed · Cited by 86
Meadows, C. A., Risbano, M. G., Zhang, L., Geraci, M. W., Tuder, R. M., Collier, D. H., & Bull, T. M. (2010) · CHEST Journal · doi:10.1378/chest.10-0302 · Cited by 86
Self-citationShitrit, D., Amital, A., Peled, N., Raviv, Y., Medalion, B., Saute, M., & Kramer, M. R. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.00958.x · Cited by 84
Santis, M. D., Bosello, S. L., Torre, G. L., Capuano, A., Tolusso, B., Pagliari, G., Pistelli, R., Danza, F. M., Zoli, A., & Ferraccioli, G. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-96 · Cited by 75
Clements, P. J., Tan, M., McLaughlin, V. V., Oudiz, R. J., Tapson, V. F., Channick, R. N., Rubin, L. J., & Langer, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200265 · Cited by 75
Pulmonary hypertension in collagen vascular disease: Table 1—
Hoeper, M. M. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.01512001 · Cited by 73
Τzouvelekis, Α., Galanopoulos, N. G., Bouros, E., Kolios, G. C., Zacharis, G., Ntolios, P., Koulelidis, A., Oikonomou, A., & Bouros, D. (2012) · Pulmonary Medicine · doi:10.1155/2012/143637 · Cited by 69
Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
Morelli, S., Barbieri, C., Sgreccia, A., Ferrante, L., Pittoni, V., Conti, F., Gualdi, G. F., Polettini, E., Carlesimo, O. A., & Calvieri, S. (1997) · PubMed · Cited by 68
New perspectives for the treatment of pulmonary hypertension
Baliga, R. S., MacAllister, R. J., & Hobbs, A. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01164.x · Cited by 68
Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension.
Johnson, S. R., Patsios, D., Hwang, D. M., et al. (2006) · PubMed · Cited by 67
Risbano, M. G., Meadows, C. A., Coldren, C. D., Jenkins, T. J., Edwards, M. G., Collier, D. H., Huber, W., Mack, D. G., Fontenot, A. P., Geraci, M. W., et al. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00218.x · Cited by 64
Self-citationTreatment of pulmonary arterial hypertension: The role of prostacyclin and prostaglandin analogs
Safdar, Z. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.12.018 · Cited by 59
Small airways in progressive systemic sclerosis (PSS)
Bjerke, R. D., Tashkin, D. P., Clements, P. J., et al. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90528-x · Cited by 58
The Spectrum of Scleroderma Lung Disease
Highland, K. B., Garin, M. C., & Brown, K. R. (2007) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2007-985613 · Cited by 47
Self-citationBecker, M., Brückner, C. S., Scherer, H. U., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137935 · Cited by 45
Daily Cyclophosphamide for Scleroderma
Wells, A. U., Latsi, P. I., & McCune, W. J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1185ed · Cited by 29
Chausow, A., Kane, T., Levinson, D., et al. (1984) · PubMed · doi:10.1164/arrd.1984.130.1.142 · Cited by 17
Bronchoalveolar Cellular Analysis in Scleroderma Lung Disease
Baughman, R. P., & Raghu, G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1490ed · Cited by 17
Self-citationSpontaneous Pneumothorax in Scleroderma
Yoon, J., Finger, D. R., & Pina, J. S. (2004) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000135557.49432.56 · Cited by 9
Saggar, R., Khanna, D., Mayes, M. D., Clements, P. J., Maranian, P., & Furst, D. E. (2010) · doi:10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3991 · Cited by 6
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Cottin, V., Hirani, N. A., Hotchkin, D. L., Nambiar, A. M., Ogura, T., Otaola, M., Skowasch, D., Park, J. S., Poonyagariyagorn, H. K., Wuyts, W., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0076-2018 · Cited by 652
Systemic sclerosis-associated interstitial lung disease
Perelas, A., Silver, R. M., Arrossi, A. V., & Highland, K. B. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30480-1 · Cited by 422
Fibrosing interstitial lung diseases: knowns and unknowns
Cottin, V., Wollin, L., Fischer, A., Quaresma, M., Stowasser, S., & Harari, S. (2019) · European Respiratory Review · doi:10.1183/16000617.0100-2018 · Cited by 336
Self-citationHoffmann-Vold, A.-M., Maher, T. M., Philpot, E. E., Ashrafzadeh, A., Barake, R., Barsotti, S., Bruni, C., Carducci, P., Carreira, P. E., Castellví, I., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30144-4 · Cited by 310
Characterisation of patients with interstitial pneumonia with autoimmune features
Oldham, J. M., Adegunsoye, A., Valenzi, E., Lee, C., Witt, L., Chen, L., Husain, A. N., Montner, S., Chung, J. H., Cottin, V., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01565-2015 · Cited by 275
Self-citation
Metadata
- Authors
- Solomon, J. J., Olson, A. L., Fischer, A., Bull, T., Brown, K. K., & Raghu, G.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2013-02-28
- Volume
- 22
- Issue
- 127
- Pages
- 6-19
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2098971028
- Cited by
- 294
- References
- 115
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.